+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Complex antioxidant relationships and derangements in premature infants with respiratory distress syndrome and bronchopulmonary dysplasias



Complex antioxidant relationships and derangements in premature infants with respiratory distress syndrome and bronchopulmonary dysplasias



Pediatric Research 35(4 Part 2): 51A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030658277

Download citation: RISBibTeXText


Related references

Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia. American Journal of Perinatology 20(2): 97-107, 2003

Incidence of bronchopulmonary dysplasia in the course of the respiratory distress syndrome in premature infants. Rofo 141(2): 167-171, 1984

Adenosine deaminase levels in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia. Journal of Maternal-Fetal and Neonatal Medicine 24(5): 703-707, 2011

Vitamin E and selenium levels of premature infants with severe respiratory distress syndrome and bronchopulmonary dysplasia. Journal of Pediatric & Perinatal Nutrition 2(1): 35-49, 1988

Incidence of bronchopulmonary dysplasia in premature infants with respiratory distress syndrome not receiving exogenous surfactant treatment. Pediatric Research 35(4 Part 2): 285A, 1994

Postnatal changes in colloid osmotic pressure in premature infants: in healthy infants, in infants with respiratory distress syndrome, and in infants born to mothers with premature rupture of membranes. Gynecologic and Obstetric Investigation 24(2): 95-100, 1987

Dornase alfa in premature infants with severe respiratory distress and early bronchopulmonary dysplasia. Journal of Perinatology 20(8 Pt 1): 530-534, 2001

Prevention and therapy of respiratory distress syndrome in premature infants by means of bromhexine metabolite VIII. Animal experimental studies on the therapeutic efficacy of bromhexine metabolite VIII in premature respiratory distress syndrome. Fortschritte der Medizin 95(25): 2145-2148, 1977

Measuring serial levels of interleukin-6 and interleukin-1B in tracheal lavage fluid of premature infants with respiratory distress syndrome does not help in determining the optimal timing for the administration of steroids in the prevention of bronchopulmonary dysplasia. Pediatric Research 45(4 Part 2): 204A, 1999

Respiratory distress syndrome in premature and newborn infants. 2. Therapy of respiratory distress syndrome. Zeitschrift für Arztliche Fortbildung 67(13): 633-641, 1973

In vitro effects of inosine-pyruvate-phosphate on P50 values and DPG contents of fresh and stored blood from healthy neonates, symptom-free premature infants and premature infants with respiratory distress syndrome. Biology of the Neonate 33(1-2): 25-30, 1978

Early respiratory management of respiratory distress syndrome in very preterm infants and bronchopulmonary dysplasia: a case-control study. Plos One 2(2): E192, 2007

Risk of infection in premature infants with premature rupture of fetal membranes in correlation to respiratory distress syndrome. Zeitschrift für Geburtshilfe und Perinatologie 192(6): 259-262, 1988

Bronchopulmonary dysplasia associated with oxygen therapy in infants with respiratory distress syndrome. Radiology 105(1): 107-112, 1972

Distribution of antioxidant enzymes in developing human lung, respiratory distress syndrome, and bronchopulmonary dysplasia. Journal of Histochemistry and Cytochemistry 52(9): 1231-1240, 2004